1. Department of Cardiac Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
2. Institute of Pharmacology and Toxicology, University Medical Center Goettingen (UMG), Göttingen, Germany.
3. German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
4. Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
5. Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
6. CancerCare Manitoba Research Institute, Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
7. VIB, Flanders Institute for Biotechnology, Ghent University, Ghent, Belgium.
8. German Center for Cardiovascular Research (DZHK), Partner site Rhein/Main, Bad Nauheim, Germany.